Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

Effect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative Tinnitus

A legfontosabb adatok

Ki végzi
Cochlear
Hol
Spanyolország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
14 fő, tervezett
Kezdés
2027. febr.
Várható befejezés
2028. ápr.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Cochlear implant
A regiszteradat frissítve
2026. november 10.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with moderate to severe tinnitus (ringing in the ears) and hearing loss who can have a cochlear implant. They will get a totally implantable cochlear implant in one ear.

Életkor
18 years and older
Nem
All sexes
A betegség stádiuma
Moderate to severe tinnitus, with a THI score above 38 (Grade 3 / Moderate or greater). Tinnitus at this level for less than 3 years. Hearing loss that meets local rules for a cochlear implant.
Korábbi kezelés
Usual tinnitus treatments, including Tinnitus Retraining Therapy (TRT), must have failed for at least 6 months. People who already had a cochlear implant in either ear cannot join.

A részvétel fő kizáró okai

  • Prior cochlear implant in either ear, or a plan for one in the other ear during the trial
  • Certain tinnitus types, such as pulsing tinnitus from blood flow, tinnitus from the brain, or after injury
  • Middle ear infection or eardrum hole in the ear to be implanted within 3 months
  • Severe hearing loss in both ears before age 5, or for more than 15 years in the ear to be implanted
  • Pregnant women

A regiszter feltételei, szó szerint

Mind a 29 feltétel megnézéseKevesebb

Ki vehet részt

  • Individuals aged 18 years and older at time of consent
  • Meets local candidacy criteria for cochlear implantation in the ear to be implanted
  • Failure to satisfactorily treat tinnitus with conventional treatments including Tinnitus Retraining Therapy (TRT) for at least six (6) months as determined by the investigator
  • Moderate to severe tinnitus handicap as determined by >38 THI score (Grade 3 / Moderate or greater)
  • Duration of moderate to severe tinnitus < 3 years, as determined by the investigator
  • Willing to undergo unilateral cochlear implantation
  • Candidate is a fluent speaker in the language used to assess speech perception performance as determined by the investigator (i.e. Spanish)
  • Direct access to a compatible Smart Phone
  • Willing and able to provide written informed consent

Ki nem vehet részt

  • Prior cochlear implantation, in either ear, or medical plan for cochlear implantation during the clinical investigation, contralateral to the ear to be implanted; Participants who meet any of the exclusion criteria described below will not be eligible for this clinical investigation
  • Prior cochlear implantation, in either ear, or medical plan for cochlear implantation during the clinical investigation, contralateral to the ear to be implanted
  • Middle ear infection (including acute otitis media, chronic otitis media, suppurative otitis media, or serous drainage) in the ear to be implanted either at the time of surgery or within 3 months prior to enrolment
  • Presence of a tympanic membrane perforation or a history of otologic surgery within 3 months prior to enrolment, in the ear to be implanted
  • Previously reported diagnosis of auditory neuropathy, in the ear to be implanted
  • Severe, or poorer, bilateral sensorineural hearing loss prior to 5 years of age, as reported by the participant
  • Unrealistic expectations on the part of the participant, regarding the possible benefits, risks, and limitations inherent to the surgical procedure(s) and prosthetic devices, as determined by the Investigator
  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device that is different from the device in this study
  • Current cerebrospinal fluid (CSF) shunts or drains, existing perilymph fistula, skull fracture or CSF leaks
  • Medical or psychological conditions that contraindicate general anaesthesia, surgery, or participation in the clinical investigation as determined by the investigator
  • Preexisting skin condition that could jeopardize wound healing, as determined by the investigator e.g., psoriasis, dermatitis, use of corticosteroids, uncontrolled diabetes
  • Tinnitus of central origin, pulsatile tinnitus related to blood flow, paroxysmal tinnitus, somatosensory tinnitus, tinnitus related to vertigo or headache, or post-traumatic tinnitus, as determined by the investigator
  • Intra-axial (within-the-brain) lesions or deafness due to lesions of the acoustic nerve affecting the ear to be implanted
  • Cochlear ossification, cochlear malformation or any other cochlear anomaly, such as common cavity, that might prevent complete insertion of the electrode array, in the ear to be implanted
  • Severe, or poorer, sensorineural hearing loss for more than 15 years, as reported by the participant, in the ear to be implanted
  • Additional disabilities that may affect the participant's participation or safety during the clinical investigation
  • Pregnant women
  • Investigator site personnel directly affiliated with this study and/or their immediate families. Immediate family is defined as spouse, parent, child or sibling
  • Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of the investigation
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this study is to investigate the degree of benefit to tinnitus symptoms by using a Totally Implantable cochlear implant (TICI) in a group of patients who have moderate-to-severe tinnitus pre-operatively.

A vizsgálat csoportja

  • Totally Implantable Cochlear Implant SystemA vizsgált kezelés

    Participants will be implanted with the TI1132 implant

    Kezelés: Cochlear implant

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Prospective, Interventional, Repeated Measures Feasibility Study to Evaluate Change in Tinnitus Severity for Adult Recipients of a Totally Implantable Cochlear Implant System Who Experience Tinnitus Pre-Operatively
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. november 10.